The augmentation and release of specific immune phenotypes, notably CD4 regulatory T cells, CD80-expressing granulocytes, and CD86-positive monocytes, have been pinpointed as contributors to the risk profile for KC. This evidence concerns the gene CD80 and keratoconus.